In an SEC filing published on Tuesday in the US, Getty said it is “not required to accept” approval conditions outlined by the UK Competitions and Markets Authority in May that require Shutterstock to sell its global editorial business, including the Backgrid and Splash paparazzi agencies.
Those conditions have proved unappealing enough for Getty to walk away from the deal, which aimed to combine the companies stock photo libraries. Both companies face competition from AI image generators that provide fast and cheap media content on demand. The company’s board of directors “unanimously” voted to terminate the merger agreement on July 6th, “assuming no material change in the aforementioned circumstances” occurs before July 7th. That essentially leaves the Getty/Shutterstock merger dead in the water.
In an SEC filing published on Tuesday in the US, Getty said it is “not required to accept” approval conditions outlined by the UK Competitions and Markets Authority in May that require Shutterstock to sell its global editorial business, including the Backgrid and Splash paparazzi agencies.
Those conditions have proved unappealing enough for Getty to walk away from the deal, which aimed to combine the companies stock photo libraries. Both companies face competition from AI image generators that provide fast and cheap media content on demand. The company’s board of directors “unanimously” voted to terminate the merger agreement on July 6th, “assuming no material change in the aforementioned circumstances” occurs before July 7th. That essentially leaves the Getty/Shutterstock merger dead in the water.
#Cleared #derailed #Gettys #Shutterstock #merger #fallsBusiness,News,Policy,Politics,Regulation,Tech">Cleared by the US, derailed by the UK: Getty’s Shutterstock merger falls apart
Getty is planning to axe its $3.7 billion merger agreement with Shutterstock after a UK regulator imposed restrictions that would prevent part of Shutterstock’s business from being included in the deal. The move comes despite the US Department of Justice granting the deal “unconditional antitrust clearance” in February.
In an SEC filing published on Tuesday in the US, Getty said it is “not required to accept” approval conditions outlined by the UK Competitions and Markets Authority in May that require Shutterstock to sell its global editorial business, including the Backgrid and Splash paparazzi agencies.
Those conditions have proved unappealing enough for Getty to walk away from the deal, which aimed to combine the companies stock photo libraries. Both companies face competition from AI image generators that provide fast and cheap media content on demand. The company’s board of directors “unanimously” voted to terminate the merger agreement on July 6th, “assuming no material change in the aforementioned circumstances” occurs before July 7th. That essentially leaves the Getty/Shutterstock merger dead in the water.
नईदुनिया प्रतिनिधि, इंदौर। सोमवार को हुए नेता प्रतिपक्ष सोनिला मिमरोट के पदभार ग्रहण कार्यक्रम में…
China’s Zhipu AI (Z.ai) released its open-weight GLM-5.2, and some researchers have claimed that it matches Mythos in certain bug-finding and cybersecurity scenarios. While GLM lags behind models from Anthropic and OpenAI in other, more general tasks, it seems that China has dramatically reduced the gap in the capabilities between its models and those of the US.
This level of advancement is particularly concerning to the US government, which has worked to restrict China’s access to powerful models like Anthropic’s Mythos and Fable, as well as the hardware necessary to train and run them. The Trump administration views Mythos and other advanced AI models capable of identifying vulnerabilities as serious national security threats. Recently, OpenAI unveiled GPT-5.6, which has also raised concerns about its potential for misuse and has limited access to it.
Because GLM is an open-weight model, it can be downloaded and run by anyone on readily available hardware. That gives it great flexibility and allows power users deep access, but it also makes it ripe for abuse by bad actors who can run it with little oversight.
China’s Zhipu AI (Z.ai) released its open-weight GLM-5.2, and some researchers have claimed that it matches Mythos in certain bug-finding and cybersecurity scenarios. While GLM lags behind models from Anthropic and OpenAI in other, more general tasks, it seems that China has dramatically reduced the gap in the capabilities between its models and those of the US.
This level of advancement is particularly concerning to the US government, which has worked to restrict China’s access to powerful models like Anthropic’s Mythos and Fable, as well as the hardware necessary to train and run them. The Trump administration views Mythos and other advanced AI models capable of identifying vulnerabilities as serious national security threats. Recently, OpenAI unveiled GPT-5.6, which has also raised concerns about its potential for misuse and has limited access to it.
Because GLM is an open-weight model, it can be downloaded and run by anyone on readily available hardware. That gives it great flexibility and allows power users deep access, but it also makes it ripe for abuse by bad actors who can run it with little oversight.
#Chinas #Z.ai #claims #match #Mythos #cybersecurityAI,News,Policy,Politics,Security,Tech">China’s Z.ai claims it can match Mythos on cybersecurity
China’s Zhipu AI (Z.ai) released its open-weight GLM-5.2, and some researchers have claimed that it matches Mythos in certain bug-finding and cybersecurity scenarios. While GLM lags behind models from Anthropic and OpenAI in other, more general tasks, it seems that China has dramatically reduced the gap in the capabilities between its models and those of the US.
This level of advancement is particularly concerning to the US government, which has worked to restrict China’s access to powerful models like Anthropic’s Mythos and Fable, as well as the hardware necessary to train and run them. The Trump administration views Mythos and other advanced AI models capable of identifying vulnerabilities as serious national security threats. Recently, OpenAI unveiled GPT-5.6, which has also raised concerns about its potential for misuse and has limited access to it.
Because GLM is an open-weight model, it can be downloaded and run by anyone on readily available hardware. That gives it great flexibility and allows power users deep access, but it also makes it ripe for abuse by bad actors who can run it with little oversight.
They won bipartisan allies from Bernie Sanders to Rand Paul, and helped create a billion-dollar industry out of kratom, which has pain-relieving effects they said could help fight the opioid epidemic as a far safer, natural alternative to pills.
Now, many of those same pro-kratom activists are calling for a ban on products containing concentrates of one of kratom’s active components: 7-hydroxymitragynine, or 7-OH, an ultra-potent extract with opioid-like effects. And it’s causing major friction amongst consumers, sellers, and advocates of both substances.
“This is a chemically manipulated, full-blown opioid that is now in the marketplace,” claims Mac Haddow, the senior public policy fellow at the American Kratom Association, a kratom industry lobby group. “They masquerade as kratom products.”
The proliferation of 7-OH in gummies, capsules, and shots with brand names like Magic 7OH, 7 O’Heaven, and Pure OHMS across thousands of gas stations and corner stores over the past few years has caused increasing consternation. Consumers of 7-OH have spoken of its excruciating withdrawal symptoms, and there have been reports of polydrug overdoses involving 7-OH and other substances. Some are now entering rehab to overcome their dependency, while others are self-detoxing based on advice from Redditors.
The kratom community fears that 7-OH’s bad reputation could drag the entire kratom industry into a regulatory quagmire. But the 7-OH industry has organized against the potential prohibition, claiming 7-OH is kratom, despite only appearing in trace amounts within the leaves of the kratom plant, and that its benefits as an analgesic outweigh its potential harms.
Anti-7-OH directives from the federal government have exacerbated tensions between the two sides.
Last July, US Health and Human Services secretary Robert F. Kennedy Jr. described the 7-OH industry as “sinister” at a press conference where FDA commissioner Marty Makary called for the DEA to categorize the drug as Schedule I—the most restrictive class of banned substances. Speaking from the Oval Office on May 11, President Donald Trump publicly endorsed “natural 7-OH,” in confusing remarks which appeared to refer to kratom. On top of all that, it appears that both RFK Jr. and Department of Homeland Security secretary Markwayne Mullin—who is also pushing for a 7-OH crackdown—have strong ties to a kratom lobbyist (and convicted criminal) behind a notorious kratom drinks company.
Proponents of 7-OH see the substance and the plant it’s derived from as inexorably linked. In April 2025 testimony to Colorado legislators debating how to regulate kratom and 7-OH, Michele Ross, the chief scientific adviser to the 7-OH advocacy group 7-HOPE Alliance, wrote, “To say 7-OH is not kratom is to say caffeine is not coffee or THC is not cannabis. It simply does not make sense.”
But as opposed to coffee, cannabis, and kratom—which have been consumed for centuries if not thousands of years—7-OH does not have a long history of human use. It’s only been on the market for a few years.
Many of the products that are labeled 7-OH contain little-understood compounds with unknown biological effects in animals or humans, says Chris McCurdy, a leading kratom researcher and director of the University of Florida’s translational drug development core. “So, these products, while represented as ‘clean’ are anything but.”
Meanwhile, a dozen states, from California to Vermont, according to reports, have already moved ahead of federal scheduling with their own 7-OH bans. Seven of those states have also banned kratom, although Rhode Island recently overturned its prohibition.
#Kratom #Civil #War #Heating #MAHA #Picked #Sidemedicine,health,politics,government,drugs,robert f. kennedy jr.">
They won bipartisan allies from Bernie Sanders to Rand Paul, and helped create a billion-dollar industry out of kratom, which has pain-relieving effects they said could help fight the opioid epidemic as a far safer, natural alternative to pills.
Now, many of those same pro-kratom activists are calling for a ban on products containing concentrates of one of kratom’s active components: 7-hydroxymitragynine, or 7-OH, an ultra-potent extract with opioid-like effects. And it’s causing major friction amongst consumers, sellers, and advocates of both substances.
“This is a chemically manipulated, full-blown opioid that is now in the marketplace,” claims Mac Haddow, the senior public policy fellow at the American Kratom Association, a kratom industry lobby group. “They masquerade as kratom products.”
The proliferation of 7-OH in gummies, capsules, and shots with brand names like Magic 7OH, 7 O’Heaven, and Pure OHMS across thousands of gas stations and corner stores over the past few years has caused increasing consternation. Consumers of 7-OH have spoken of its excruciating withdrawal symptoms, and there have been reports of polydrug overdoses involving 7-OH and other substances. Some are now entering rehab to overcome their dependency, while others are self-detoxing based on advice from Redditors.
The kratom community fears that 7-OH’s bad reputation could drag the entire kratom industry into a regulatory quagmire. But the 7-OH industry has organized against the potential prohibition, claiming 7-OH is kratom, despite only appearing in trace amounts within the leaves of the kratom plant, and that its benefits as an analgesic outweigh its potential harms.
Anti-7-OH directives from the federal government have exacerbated tensions between the two sides.
Last July, US Health and Human Services secretary Robert F. Kennedy Jr. described the 7-OH industry as “sinister” at a press conference where FDA commissioner Marty Makary called for the DEA to categorize the drug as Schedule I—the most restrictive class of banned substances. Speaking from the Oval Office on May 11, President Donald Trump publicly endorsed “natural 7-OH,” in confusing remarks which appeared to refer to kratom. On top of all that, it appears that both RFK Jr. and Department of Homeland Security secretary Markwayne Mullin—who is also pushing for a 7-OH crackdown—have strong ties to a kratom lobbyist (and convicted criminal) behind a notorious kratom drinks company.
Proponents of 7-OH see the substance and the plant it’s derived from as inexorably linked. In April 2025 testimony to Colorado legislators debating how to regulate kratom and 7-OH, Michele Ross, the chief scientific adviser to the 7-OH advocacy group 7-HOPE Alliance, wrote, “To say 7-OH is not kratom is to say caffeine is not coffee or THC is not cannabis. It simply does not make sense.”
But as opposed to coffee, cannabis, and kratom—which have been consumed for centuries if not thousands of years—7-OH does not have a long history of human use. It’s only been on the market for a few years.
Many of the products that are labeled 7-OH contain little-understood compounds with unknown biological effects in animals or humans, says Chris McCurdy, a leading kratom researcher and director of the University of Florida’s translational drug development core. “So, these products, while represented as ‘clean’ are anything but.”
Meanwhile, a dozen states, from California to Vermont, according to reports, have already moved ahead of federal scheduling with their own 7-OH bans. Seven of those states have also banned kratom, although Rhode Island recently overturned its prohibition.
#Kratom #Civil #War #Heating #MAHA #Picked #Sidemedicine,health,politics,government,drugs,robert f. kennedy jr.">The Kratom Civil War Is Heating Up, and MAHA Has Picked a Side
A decade ago,kratom advocates fought a surprisingly successful campaign against a proposedDrug Enforcement Administration ban that claimed the obscure Southeast Asian plant posed “an imminent hazard to public safety.”
They won bipartisan allies from Bernie Sanders to Rand Paul, and helped create a billion-dollar industry out of kratom, which has pain-relieving effects they said could help fight the opioid epidemic as a far safer, natural alternative to pills.
Now, many of those same pro-kratom activists are calling for a ban on products containing concentrates of one of kratom’s active components: 7-hydroxymitragynine, or 7-OH, an ultra-potent extract with opioid-like effects. And it’s causing major friction amongst consumers, sellers, and advocates of both substances.
“This is a chemically manipulated, full-blown opioid that is now in the marketplace,” claims Mac Haddow, the senior public policy fellow at the American Kratom Association, a kratom industry lobby group. “They masquerade as kratom products.”
The proliferation of 7-OH in gummies, capsules, and shots with brand names like Magic 7OH, 7 O’Heaven, and Pure OHMS across thousands of gas stations and corner stores over the past few years has caused increasing consternation. Consumers of 7-OH have spoken of its excruciating withdrawal symptoms, and there have been reports of polydrug overdoses involving 7-OH and other substances. Some are now entering rehab to overcome their dependency, while others are self-detoxing based on advice from Redditors.
The kratom community fears that 7-OH’s bad reputation could drag the entire kratom industry into a regulatory quagmire. But the 7-OH industry has organized against the potential prohibition, claiming 7-OH is kratom, despite only appearing in trace amounts within the leaves of the kratom plant, and that its benefits as an analgesic outweigh its potential harms.
Anti-7-OH directives from the federal government have exacerbated tensions between the two sides.
Last July, US Health and Human Services secretary Robert F. Kennedy Jr. described the 7-OH industry as “sinister” at a press conference where FDA commissioner Marty Makary called for the DEA to categorize the drug as Schedule I—the most restrictive class of banned substances. Speaking from the Oval Office on May 11, President Donald Trump publicly endorsed “natural 7-OH,” in confusing remarks which appeared to refer to kratom. On top of all that, it appears that both RFK Jr. and Department of Homeland Security secretary Markwayne Mullin—who is also pushing for a 7-OH crackdown—have strong ties to a kratom lobbyist (and convicted criminal) behind a notorious kratom drinks company.
Proponents of 7-OH see the substance and the plant it’s derived from as inexorably linked. In April 2025 testimony to Colorado legislators debating how to regulate kratom and 7-OH, Michele Ross, the chief scientific adviser to the 7-OH advocacy group 7-HOPE Alliance, wrote, “To say 7-OH is not kratom is to say caffeine is not coffee or THC is not cannabis. It simply does not make sense.”
But as opposed to coffee, cannabis, and kratom—which have been consumed for centuries if not thousands of years—7-OH does not have a long history of human use. It’s only been on the market for a few years.
Many of the products that are labeled 7-OH contain little-understood compounds with unknown biological effects in animals or humans, says Chris McCurdy, a leading kratom researcher and director of the University of Florida’s translational drug development core. “So, these products, while represented as ‘clean’ are anything but.”
Meanwhile, a dozen states, from California to Vermont, according to reports, have already moved ahead of federal scheduling with their own 7-OH bans. Seven of those states have also banned kratom, although Rhode Island recently overturned its prohibition.
#Kratom #Civil #War #Heating #MAHA #Picked #Sidemedicine,health,politics,government,drugs,robert f. kennedy jr.
A decade ago, kratom advocates fought a surprisingly successful campaign against a proposed Drug Enforcement…
Heidi Montag publicly addressed her husband Spencer Pratt’s Los Angeles mayoral loss. “I couldn’t love…
According to theWall Street Journal, the export control directive that led to Anthropic cutting off access to Fable 5 and Mythos 5 was triggered in part by cybersecurity research from Amazon and conversations between CEO Andy Jassy and the White House. According to the report, the paper from Amazon claims that, through a series of prompts, it was able to get Fable 5 to serve up information that could be used in cyberattacks. Amazon has yet to respond to a request for comment.
Shortly after Jassy shared the company’s findings with the government, it made the call to block its use by foreign nationals. Complicating this issue is that many of Anthropic’s researchers are foreign-born, meaning they were barred from accessing their own product.
In a statement, Anthropic disputed the government’s characterization of the issue as a “jailbreak.” It argued that many of the same vulnerabilities could be discovered using other publicly available models, including GPT 5.5. Some security researchers appear to back the company’s interpretation. Katie Moussouris, the founder and CEO of LutaSecurity posted on BlueSky that “I’ve seen the paper. It’s not a jailbreak.” Former Commerce Department official Kate Koren speculated to the WSJ that the White House’s dislike of Anthropic may have influenced the decision.
Anthropic and the Trump administration have been at odds for some time over the company’s refusal to allow its AI to be used for mass surveillance of Americans or to power lethal autonomous weapons. In February, Trump instructed federal agencies to stop using Anthropic’s AI. And just hours later, Secretary of Defense Pete Hegseth designated the company a supply chain risk.
The government and the company seemed to have madeamends, and the two had worked together to expand access to Mythos. However, now the two seem destined to clash again.
According to theWall Street Journal, the export control directive that led to Anthropic cutting off access to Fable 5 and Mythos 5 was triggered in part by cybersecurity research from Amazon and conversations between CEO Andy Jassy and the White House. According to the report, the paper from Amazon claims that, through a series of prompts, it was able to get Fable 5 to serve up information that could be used in cyberattacks. Amazon has yet to respond to a request for comment.
Shortly after Jassy shared the company’s findings with the government, it made the call to block its use by foreign nationals. Complicating this issue is that many of Anthropic’s researchers are foreign-born, meaning they were barred from accessing their own product.
In a statement, Anthropic disputed the government’s characterization of the issue as a “jailbreak.” It argued that many of the same vulnerabilities could be discovered using other publicly available models, including GPT 5.5. Some security researchers appear to back the company’s interpretation. Katie Moussouris, the founder and CEO of LutaSecurity posted on BlueSky that “I’ve seen the paper. It’s not a jailbreak.” Former Commerce Department official Kate Koren speculated to the WSJ that the White House’s dislike of Anthropic may have influenced the decision.
Anthropic and the Trump administration have been at odds for some time over the company’s refusal to allow its AI to be used for mass surveillance of Americans or to power lethal autonomous weapons. In February, Trump instructed federal agencies to stop using Anthropic’s AI. And just hours later, Secretary of Defense Pete Hegseth designated the company a supply chain risk.
The government and the company seemed to have madeamends, and the two had worked together to expand access to Mythos. However, now the two seem destined to clash again.
#Amazon #security #research #reportedly #led #White #Houses #Anthropic #Fable #banAI,Amazon,Anthropic,News,Policy,Politics,Security,Tech">Amazon security research reportedly led to the White House’s Anthropic Fable ban
According to theWall Street Journal, the export control directive that led to Anthropic cutting off access to Fable 5 and Mythos 5 was triggered in part by cybersecurity research from Amazon and conversations between CEO Andy Jassy and the White House. According to the report, the paper from Amazon claims that, through a series of prompts, it was able to get Fable 5 to serve up information that could be used in cyberattacks. Amazon has yet to respond to a request for comment.
Shortly after Jassy shared the company’s findings with the government, it made the call to block its use by foreign nationals. Complicating this issue is that many of Anthropic’s researchers are foreign-born, meaning they were barred from accessing their own product.
In a statement, Anthropic disputed the government’s characterization of the issue as a “jailbreak.” It argued that many of the same vulnerabilities could be discovered using other publicly available models, including GPT 5.5. Some security researchers appear to back the company’s interpretation. Katie Moussouris, the founder and CEO of LutaSecurity posted on BlueSky that “I’ve seen the paper. It’s not a jailbreak.” Former Commerce Department official Kate Koren speculated to the WSJ that the White House’s dislike of Anthropic may have influenced the decision.
Anthropic and the Trump administration have been at odds for some time over the company’s refusal to allow its AI to be used for mass surveillance of Americans or to power lethal autonomous weapons. In February, Trump instructed federal agencies to stop using Anthropic’s AI. And just hours later, Secretary of Defense Pete Hegseth designated the company a supply chain risk.
The government and the company seemed to have madeamends, and the two had worked together to expand access to Mythos. However, now the two seem destined to clash again.
